The health and safety of our patients, families and staff remain our top priorities as we face the challenges brought on by the COVID-19 pandemic. Our teams at Dana-Farber/Brigham and Women’s Cancer Center are devoted to providing compassionate care to all of our patients and cancer survivors.
We understand that you may have concerns during this difficult time, but know we are steadfast in our commitment to safely providing lifesaving cancer treatment. We’re here to ensure you receive the critical care you need and help you achieve the best possible outcomes.
“Our care team makes treatment decisions with each patient in mind, and now more than ever, the team is making decisions very thoughtfully and carefully in the COVID context. As always, we offer team-oriented, collaborative, cutting-edge, specialized cancer care centered on you.” Daphne Haas-Kogan, MD, Chair, Department of Radiation Oncology
Visit our COVID-19 FAQ For Cancer Patients for details into the safety measures we’re taking to provide safe, high-quality care for you and your loved one at this time.
Dr. Daphne Haas-Kogan, chair of the Department of Radiation Oncology at Dana-Farber/Brigham and Women’s Cancer Center, shares the many safety measures implemented to ensure hundreds of cancer patients continue to receive cutting-edge, patient-centered cancer care during COVID-19.
An Expression of Gratitude for Compassionate Cancer Care During COVID-19
Matt, whose partner Lina is undergoing treatment for a brain tumor, expresses sincere gratitude to the Radiation Oncology team at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC). His moving message of appreciation and hope are featured in this video.
About Radiation Oncology
The Radiation Oncology Department at Brigham and Women’s Hospital (BWH) is one of the premier radiation treatment programs in the world. We are the radiation therapy team for Brigham and Women’s Hospital, Dana-Farber/Brigham and Women’s Cancer Center, and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Our care providers will work with you and your other cancer care providers as a team to develop and implement a safe, customized radiation therapy plan that’s right for you.
Dana-Farber/Brigham and Women’s Cancer Center is proud to be the first cancer center in New England to offer access to cutting-edge, MRI-guided radiation therapy. It is a new high-precision radiation treatment that targets tumors with high doses of radiation while minimizing damage to normal healthy tissues. Magnetic resonance imaging (MRI) uses powerful magnets to generate images of your body and has several advantages over traditional X-ray-based imaging, including:
Improved targeting of cancers located in soft tissues, including cancers of the breast, gastrointestinal tract, head and neck, lung, prostate, uterus and cervix, and a variety of other locations.
Continuous imaging to track the location of the tumor during treatment.
This new MRI-guided radiation technology available at our center will help us to target your cancer more accurately and adapt the radiation plan based on where your cancer and organs are moving each day.
For the first time, cancer patients in New England will have a cutting-edge option for radiation treatment, known as MRI-Guided Radiation Therapy (MRI-RT). This video highlights the two components of the new MRI-RT, a 3 Tesla MRI scanner modified for radiation therapy planning called the MR Advanced Procedure and Simulation (MAPS) unit and an integrated MRI-guided linear accelerator (MRI-LINAC). The MAPS unit includes a high-field strength (3.0T) magnet for diagnostic quality imaging for initial radiation therapy planning. The MRI-LINAC, meanwhile, is a state-of-the-art hybrid device that integrates a modified, lower-field (0.35T) MRI scanner with a linear accelerator (radiation delivery machine) to reduce the magnetic interference on the radiation beam.